Financial News · Live Terminal

Page 12 of 193

Selective Insurance Shares Rise after BMO Capital Upgrade

Selective Insurance (SIGI) shares rose 1.9% in afternoon trading Thursday after BMO Capital upgraded the stock to outperform from market perform and boosted its price target to $97 per share from $84.Trading volume stood at nearly 385,000 shares, compared with a daily average of about 563,000.Price: $84.60, Change: $+1.60, Percent Change: +1.92%

$SIGI

Australia2d ago

Argus Lowers Price Target on KKR to $115 From $120

KKR (KKR) has an average rating of buy and mean price target of $123.94, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $100.51, Change: $-0.28, Percent Change: -0.28%

$KKR

Australia2d ago

Citigroup Lifts Price Target on Williams to $83 From $81

Williams (WMB) has an average rating of overweight and mean price target of $83.05, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $72.61, Change: $-1.15, Percent Change: -1.56%

$WMB

Australia2d ago

TD Cowen Adjusts Datadog Price Target to $235 From $190, Maintains Buy Rating

Datadog (DDOG) has an average rating of overweight and mean price target of $179.93, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $186.94, Change: $+43.23, Percent Change: +30.08%

$DDOG

Australia2d ago

Mizuho Securities Adjusts Datadog Price Target to $220 From $145, Maintains Outperform Rating

Datadog (DDOG) has an average rating of buy and mean price target of $177.97, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $187.00, Change: $+43.29, Percent Change: +30.12%

$DDOG

Australia2d ago

Barclays Lowers McDonald's Price Target to $350 From $380

McDonald's (MCD) has an average rating of overweight and mean price target of $346.87, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $284.34, Change: $+0.24, Percent Change: +0.08%

$MCD

Australia2d ago

Baird Cuts Price Target on McDonald's to $305 From $330, Maintains Neutral Rating

McDonald's (MCD) has an average rating of overweight and mean price target of $343.53, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $284.27, Change: $+0.16, Percent Change: +0.06%

$MCD

Australia2d ago

Truist Securities Raises Datadog $190 From $120, Hold Rating Kept

$DDOG

Australia2d ago

Jumia Technologies Shares Rise After Q1 Revenue Increases

Jumia Technologies (JMIA) shares rose 16% in afternoon trading on Thursday after the company posted higher Q1 revenue.The company reported a Q1 operating loss of $13.9 million, narrower than loss of $18.7 million a year earlier.Revenue for the quarter ended March 31 was $50.6 million, up from $36.3 million a year earlier.Four analysts polled by FactSet expected revenue of $46.5 million.Price: $8.70, Change: $+1.24, Percent Change: +16.62%

$JMIA

Australia2d ago

Update: Himax Shares Soar After Q1 Results, Q2 Guidance

Himax Technologies (HIMX) shares were up almost 30% Thursday afternoon following its Q1 results and Q2 guidance.Earlier, the company reported Q1 earnings of $0.046 per diluted American depositary share, down from $0.114 a year earlier.Two analysts polled by FactSet expected $0.05 for the fabless manufacturer of display drivers and other products in Taiwan.Revenue for the quarter ended March 31 was $199.0 million, compared with $215.1 million a year earlier.A single analyst expected $195 million in a FactSet poll.The company said it expects Q2 earnings of $0.09 to $0.10 per diluted ADS on net revenue growth of 10% to 13% sequentially. Two analysts expect earnings of $0.06.Price: $15.90, Change: $+3.57, Percent Change: +28.95%

$HIMX

Australia2d ago

Entrada Therapeutics Shares Decline After Duchenne Muscular Dystrophy Drug Reportedly Misses Analyst Expectations

Entrada Therapeutics (TRDA) shares were down nearly 58% in Thursday afternoon trading after its drug for children with Duchenne muscular dystrophy fell short of analyst expectations in an early-to-mid stage trial, Reuters reported Thursday.Entrada said Thursday that treated patients showed a 2.36% increase in dystrophin over a baseline of 4%.William Blair analyst Myles Minter expected a placebo-adjusted dystrophin increase of at least 10% as his base case for the drug, while the firm's own model estimated around 11%, Reuters reported.The data also compares unfavorably with del-zota, Avidity Biosciences' rival exon-44 skipping drug, which reported placebo-adjusted dystrophin increases of around 25% in its early-to-mid stage trial. Oppenheimer analysts had set that benchmark for Entrada's success as well, Reuters said.Price: $6.77, Change: $-9.26, Percent Change: -57.77%

$TRDA

Australia2d ago

Alpha and Omega Semiconductor Shares Fall After Fiscal Q3 Adjusted Loss Widens

Alpha and Omega Semiconductor (AOSL) shares fell 26% in intraday trading Thursday, a day after the company reported wider Q3 loss.After markets closed on Wednesday, the company reported fiscal Q3 adjusted loss of $0.28 per diluted share, compared with loss of $0.10 a year earlier.Three analysts polled by FactSet expected loss of $0.36.Revenue for the quarter ended March 31 was $163.8 million, down from $164.6 million a year ago.Three analysts surveyed by FactSet expected $160.1 million.The company expects fiscal Q4 revenue of about $168 million, plus or minus $10 million.Three analysts polled by FactSet expect $168.0 million.Price: $36.54, Change: $-12.79, Percent Change: -25.93%

$AOSL

Australia2d ago

Update: Planet Fitness Shares Fall After Company Lowers 2026 Sales Guidance

(Updates with the latest stock movement in the first paragraph and headline.)Planet Fitness (PLNT) shares were down 31% in Thursday trading after the company lowered its 2026 sales guidance.The company reported Q1 adjusted earnings Thursday of $0.74 per diluted share, up from $0.59 a year earlier.Analysts polled by FactSet expected $0.63.Revenue for the quarter ended March 31 was $337.2 million, compared with $276.7 million a year earlier.Analysts surveyed by FactSet expected $298.6 million.For 2026, the company expects revenue growth of about 7%, compared with its prior sales growth guidance of 9%. Analysts are looking for $1.45 billion.Price: $44.11, Change: $-19.86, Percent Change: -31.04%

$PLNT

Australia2d ago

Top Midday Decliners

Planet Fitness (PLNT) shares tumbled 32% after the company Thursday tempered its full-year outlook amid fewer-than-expected member additions in Q1.More than 12.7 million shares of the company traded intraday compared with a daily average of about 1.8 million.Zoetis (ZTS) reported Q1 adjusted earnings and revenue Thursday below market expectations, while scaling back its full-year 2026 guidance.Shares sank 20% following a surge in intraday trading volume to over 22.4 million from a daily average of about 4 million.ARM (ARM) Chief Executive Rene Haas said, in an earnings call with investors, that while demand for ARM's new AGI CPU doubled to $2 billion within six weeks of its launch, the company has only secured enough manufacturing capacity to fulfill half of those orders.Shares dropped 10%, with intraday trading volume at over 18.9 million versus a daily average of about 7.4 million.Price: $43.38, Change: $-20.59, Percent Change: -32.18%

$ARM$PLNT$ZTS

Australia2d ago

Update: Six Flags Entertainment Shares Rise After Q1 Revenue Beat

(Updates with the stock movement in the first paragraph and headline.)Six Flags Entertainment (FUN) shares rose 18% in Thursday trading after the company reported Q1 revenue that topped Wall Street estimates.Revenue in the three months ended March 29 rose to $225.6 million from $202.1 million a year earlier.Analysts surveyed by FactSet expected $207.5 million.The Q1 net loss widened to $268.6 million from $219.7 million a year earlier.Analysts surveyed by FactSet expected a loss of $293.7 million.Six Flags said Chief Financial Officer Brian Witherow will step down effective Friday. Chief Accounting Officer Dave Hoffman will serve as interim CFO while the company searches for a permanent replacement.Amy Martin Ziegenfuss will join as chief marketing officer on June 3, replacing Christian Dieckmann, who exited on May 2. Christopher Bennett will join as chief legal and compliance officer on the same day, succeeding Brian Nurse, who will leave Friday.Price: $23.18, Change: $+3.49, Percent Change: +17.72%

$FUN

Australia2d ago

Sezzle Shares Rise After Q1 Beat

Sezzle (SEZL) share rose 20% on Thursday, a day after the company reported better-than-expected Q1 financial results.The company reported Q1 adjusted earnings late Wednesday of $1.43 per diluted share, up from $0.98 a year earlier.Analysts polled by FactSet expected $1.20.Revenue for the three months ended March 31 was $135.5 million, up from $104.9 million a year earlier.Analysts surveyed by FactSet expected $127.7 million.For the full-year 2026, the company now expects adjusted EPS of $5.10 from $4.70 earlier. Analysts expect $5.09.Price: $103.99, Change: $+17.97, Percent Change: +20.89%

$SEZL

Australia2d ago

Novartis Starts Construction on Texas Cancer Therapy Manufacturing Facility

Novartis (NVS) said Thursday it started construction on a new radioligand therapy manufacturing facility in Denton, Texas, as part of the company's broader $23 billion US investment plan.The company said the Texas facility will become its fifth radioligand therapy manufacturing site in the US and is expected to begin operations in 2028, supporting production of personalized cancer therapies.The company said the project is part of its plan to expand US manufacturing and research operations over five years.Price: $145.47, Change: $-2.89, Percent Change: -1.95%

$NVS

Australia2d ago

Top Midday Gainers

Agilon Health (AGL) reported late Wednesday higher Q1 earnings, while Deutsche Bank also upgraded the company to buy from hold and raised its price target to $49 from $33.Shares more than doubled Thursday as intraday trading volume catapulted to over 3.2 million from a daily average of about 335,000.SiTime (SITM) reported stronger-than-expected Q1 adjusted earnings and revenue late Wednesday.Shares soared 25%, with intraday trading volume of over 956,200 from a daily average of about 421,000.Datadog (DDOG) raised its full-year outlook while reporting Q1 non-GAAP earnings and revenue above analysts' estimates.Shares surged 29% as intraday trading volume soared to over 19.8 million from a daily average of roughly 5.4 million.Price: $62.25, Change: $+34.40, Percent Change: +123.50%

$AGL$DDOG$SITM

Australia2d ago

QuasarEdge Plans to Acquire Robseek Intelligence

QuasarEdge Acquisition (QRED) said Thursday it has entered into a non-binding letter of intent with Robseek Intelligence to pursue a potential business combination.The blank check company said they are exploring a potential share-for-share exchange for QuasarEdge to acquire Robseek.Robseek is an infrastructure platform company building a "device + data + AI + service" ecosystem, it said.Price: $9.88, Change: $+0.01, Percent Change: +0.05%

$QRED

Australia2d ago

Update: Becton, Dickinson Shares Rise After Higher Fiscal Q2 Results; Vitor Roque Named as CFO

(Updates with the latest stock movement in the first paragraph and headline.)Becton, Dickinson (BDX) shares were up 5.6% in Thursday trading after the company reported higher fiscal Q2 results and named Vitor Roque as CFO.The company reported fiscal Q2 adjusted earnings Thursday of $2.90 per diluted share, up from $2.79 a year earlier.Analysts polled by FactSet expected $2.78.Revenue for the quarter ended March 31 was $4.71 billion, up from $4.48 billion a year earlier.Analysts surveyed by FactSet expected $4.67 billion.For 2026, the company raised its adjusted diluted EPS guidance to between $12.52 and $12.72, from its previous projection of $12.35 to $12.65. Analysts polled by FactSet expect $12.49. The company maintained its low single-digit plus revenue growth outlook.The company also said it has named interim Chief Financial Officer Vitor Roque to the post permanently, effective immediately.Roque has more than 25 years of experience and has held senior finance and operations roles in the company, Becton, Dickinson said.Price: $153.28, Change: $+8.52, Percent Change: +5.88%

$BDX

Showing 221-240 of 3847